Skip to main content

Table 3 Characteristics of patients with discordant results using the SCORE and D'Agostino equations.

From: Therapeutic implications of selecting the SCORE (European) versus the D'AGOSTINO (American) risk charts for cardiovascular risk assessment in hypertensive patients

 

SCORE high-D'AGOSTINO non-high (n = 8)

SCORE non-high-D'AGOSTINO high (n = 80)

p

Males

4 (50%)

64 (80%)

0.054

Age (years)

62.69 ± 8.83

56.41 ± 5.6

0.003

Obese (BMI > 30)

3 (37.5%)

27 (33.8%)

0.831

Smokers

1 (12.5%)

29 (36.3%)

0.177

Diabetics

5 (62.5%)

17 (21.3%)

0.010

Hyperlipidaemic

2 (25%)

55 (68.8%)

0.014

BMI

31.6 ± 7.53

28.70 ± 4.40

0.102

Waist circumference

97.5 ± 9.77

99 ± 10.39

0.697

Glucose (mg/dL)

110.50 ± 40.59

105.82 ± 31.09

0.694

Cholesterol/HDL ratio

3.06 ± 0.81

4.76 ± 1.08

0.000

Total cholesterol (mg/dL)

196.50 ± 43.39

219.79 ± 36.39

0.093

HDL-C (mg/dL)

68.25 ± 25.10

47.64 ± 10.36

0.000

LDL-C (mg/dL)

107.13 ± 27.46

140.78 ± 34.01

0.008

Triglycerides (mg/dL)

105 ± 55.10

155.55 ± 96.74

0.151

Systolic blood pressure (mmHg)

137.75 ± 18.27

146.43 ± 17.87

0.195

Diastolic blood pressure (mmHg)

83.63 ± 9.33

91.11 ± 10.97

0.066

Antihypertensive drugs

3 (37.5%)

62 (77.5%)

0.014

Lipid lowering drugs

2 (25%)

20 (25%)

1

  1. BMI: body mass index; Hyperlipidaemic: cholesterol > 200 mg/dl, HDL: high-density lipoprotein; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol. P value of the association of the typical differences and the probability of being a discordant patient (SCORE non-high-D'AGOSTINO high; SCORE high-D'AGOSTINO non-high). Data are shown as mean ± standard deviation or as number and percentages.